家族性高胆固醇血症变异与健康生活方式依从性的交互作用与冠状动脉疾病风险的关联
该横断面研究使用英国生物银行两个独立数据集:病例对照研究(4896例病例、5279例对照)和队列研究(39920人),分析家族性高胆固醇血症变异与健康生活方式依从性(4分制:健康饮食、规律运动、不吸烟、无肥胖各1分)的交互作用与冠状动脉疾病风险的关联。病例对照研究中变异携带者35/4896例(0.7%) vs 对照12/5279例(0.2%),OR 3.0(95%CI 1.6-5.9);队列研究中108人(0.3%)携带变异,HR 3.8(95%CI 2.5-5.8)。携带状态与生活方式无显著交互作用(OR 1.2,95%CI 0.6-2.5;P=0.62)。携带者中健康生活方式较不健康生活方式冠状动脉疾病风险低86%(HR 0.14,95%CI 0.04-0.41)。75岁时估计风险:非携带者健康生活方式10.2%、不健康生活方式24.0%;携带者健康生活方式34.5%、不健康生活方式66.2%。作者认为,携带家族性高胆固醇血症变异者可能从生活方式干预中获益以降低冠状动脉疾病风险。
要点
- 病例对照研究中,家族性高胆固醇血症变异携带者35/4896例(0.7%) vs 对照12/5279例(0.2%),OR 3.0(95%CI 1.6-5.9)。
- 队列研究中108人(0.3%)携带变异,冠状动脉疾病HR 3.8(95%CI 2.5-5.8)。
- 携带状态与生活方式无显著交互作用(OR 1.2,95%CI 0.6-2.5;P=0.62)。
- 携带者中健康生活方式较不健康生活方式冠状动脉疾病风险低86%(HR 0.14,95%CI 0.04-0.41)。
- 75岁时估计冠状动脉疾病风险:非携带者健康生活方式10.2%、不健康生活方式24.0%;携带者健康生活方式34.5%、不健康生活方式66.2%。
适用人群与场景
- 病例对照研究纳入入组时冠状动脉疾病患者和对照,共10175人(男性6828人[67.1%],平均[SD]年龄58.6[7.2]岁)。
- 队列研究使用有基因测序数据的便利样本,共39920人(男性18802人[47.1%],随访结束时平均[SD]年龄66.4[8.0]岁)。
- 参与者于2006年3月21日至2010年10月1日从英国22个站点招募。
诊断标准与关键阈值
- 健康生活方式采用4分制评分:健康饮食、规律运动、不吸烟、无肥胖各1分。
- 家族性高胆固醇血症变异由临床实验室遗传学家分类为致病性或可能致病性DNA变异。
研究设计与关键结果
- 研究类型:横断面研究,使用英国生物银行两个独立数据集(病例对照研究和队列研究)。
- 病例对照研究:4896例病例中35例(0.7%)检出变异,5279例对照中12例(0.2%)检出变异,OR 3.0(95%CI 1.6-5.9)。
- 队列研究:108人(0.3%)检出变异,冠状动脉疾病HR 3.8(95%CI 2.5-5.8)。
- 携带状态与生活方式交互作用无统计学意义:OR 1.2(95%CI 0.6-2.5);P=0.62。
- 携带者中,健康生活方式较不健康生活方式冠状动脉疾病风险低86%:HR 0.14(95%CI 0.04-0.41)。
- 75岁时估计冠状动脉疾病风险:非携带者健康生活方式10.2%、不健康生活方式24.0%;携带者健康生活方式34.5%、不健康生活方式66.2%。
- 主要终点:病例对照研究为心肌梗死;队列研究为心肌梗死、缺血性心脏病或冠状动脉血运重建术。
- 统计分析于2019年4月2日至2022年1月20日进行。
证据类型、等级与局限
- 证据类型:横断面研究,使用英国生物银行数据。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,携带家族性高胆固醇血症变异者与一般人群相似,可能从生活方式干预中获益以降低冠状动脉疾病风险。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Familial hypercholesterolemia variants impair clearance of cholesterol from the circulation and increase risk of coronary artery disease (CAD). The extent to which adherence to a healthy lifestyle is associated with a lower risk of CAD in carriers and noncarriers of variants warrants further study.
OBJECTIVE: To assess the association of the interaction between familial hypercholesterolemia variants and adherence to a healthy lifestyle with risk of CAD.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used 2 independent data sets with gene sequencing and lifestyle data from the UK Biobank: a case-control study of 4896 cases and 5279 controls and a cohort study of 39 920 participants. Participants were recruited from 22 sites across the UK between March 21, 2006, and October 1, 2010. The case-control study included participants with CAD and controls at enrollment. The cohort study used a convenience sample of individuals with available gene sequencing data. Statistical analysis was performed from April 2, 2019, to January 20, 2022.
EXPOSURES: Pathogenic or likely pathogenic DNA variants classified by a clinical laboratory geneticist and adherence to a healthy lifestyle based on a 4-point scoring system (1 point for each of the following: healthy diet, regular exercise, not smoking, and absence of obesity).
MAIN OUTCOMES AND MEASURES: Coronary artery disease, defined as myocardial infarction in the case-control study, and myocardial infarction, ischemic heart disease, or coronary revascularization procedure in the cohort study.
RESULTS: The case-control study included 10 175 participants (6828 men [67.1%]; mean [SD] age, 58.6 [7.2] years), and the cohort study included 39 920 participants (18 802 men [47.1%]; mean [SD] age at the end of follow-up, 66.4 [8.0] years). A variant was identified in 35 of 4896 cases (0.7%) and 12 of 5279 controls (0.2%), corresponding to an odds ratio of 3.0 (95% CI, 1.6-5.9), and a variant was identified in 108 individuals (0.3%) in the cohort study, in which the hazard ratio for CAD was 3.8 (95% CI, 2.5-5.8). However, this risk appeared to vary according to lifestyle categories in both carriers and noncarriers of familial hypercholesterolemia variants, without a significant interaction between carrier status and lifestyle (odds ratio, 1.2 [95% CI, 0.6-2.5]; P = .62). Among carriers, a favorable lifestyle conferred 86% lower risk of CAD compared with an unfavorable lifestyle (hazard ratio, 0.14 [95% CI, 0.04-0.41]). The estimated risk of CAD by the age of 75 years varied according to lifestyle, ranging from 10.2% among noncarriers with a favorable lifestyle to 24.0% among noncarriers with an unfavorable lifestyle and ranging from 34.5% among carriers with a favorable lifestyle to 66.2% among carriers with an unfavorable lifestyle.
CONCLUSIONS AND RELEVANCE: This study suggests that, among carriers and noncarriers of a familial hypercholesterolemia variant, significant gradients in risk of CAD are noted according to adherence to a healthy lifestyle pattern. Similar to the general population, individuals who carry familial hypercholesterolemia variants are likely to benefit from lifestyle interventions to reduce their risk of CAD.
参考来源
- Fahed AC, Wang M, Patel AP, et al. Association of the Interaction Between Familial Hypercholesterolemia Variants and Adherence to a Healthy Lifestyle With Risk of Coronary Artery Disease. JAMA Netw Open. 2022. PMID: 35294538. doi:10.1001/jamanetworkopen.2022.2687
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。